pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 301–400 of 1,003
p16 INK4A Participates in a G 1 Arrest Checkpoint in Response to DNA Damage
Shapiro, G. I., Edwards, C. D., Ewen, M. E., & Rollins, B. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.378 · Cited by 165
The role of RB in cell cycle control
Hatakeyama, M., & Weinberg, R. A. (1995) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-1809-9_2 · Cited by 164
Byeon, I.-J. L., Li, J., Ericson, K., Selby, T. L., Tevelev, A., Kim, H.-J., O'Maille, P., & Tsai, M.-D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80042-8 · Cited by 163
Sapkota, G., Knockaert, M., Alarcón, C., Montalvo, E., Brivanlou, A. H., & Massagué, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610172200 · Cited by 163
Molecular and Genetic Aspects of Lung Cancer
ROM, W. N., HAY, J. G., LEE, T. C., JIANG, Y., & TCHOU-WONG, K.-M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9908012 · Cited by 163
Paracrine cellular senescence exacerbates biliary injury and impairs regeneration
Ferreira-Gonzalez, S., Lu, W.-Y., Raven, A., Dwyer, B., Man, T. Y., O’Duibhir, E., Lewis, P. J. S., Campana, L., Kendall, T. J., Bird, T. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03299-5 · Cited by 161
miRNA regulation of cytokine genes
Asirvatham, A. J., Magner, W. J., & Tomasi, T. B. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.010 · Cited by 161
Emerging roles for TGF‐β1 in nervous system development
Gomes, F. C. A., Sousa, V. D. O., & Romão, L. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.04.001 · Cited by 162
“In the majority of tissue types studied, TGF-b induces growth suppression associated with the increased expression or activities of several cyclin- dependent kinase inhibitors, including p15, p21 and p27 (Hannon and Beach, 1994).”
BackgroundMelanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors
Piepkorn, M. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104687 · Cited by 162
Ishida, A., Sasaguri, T., Kosaka, C., Nojima, H., & Ogata, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10050 · Cited by 161
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Fessler, E., Drost, J., van Hooff, S. R., Linnekamp, J. F., Wang, X., Jansen, M., De Sousa E Melo, F., Prasetyanti, P. R., IJspeert, J. E., Franitza, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606184 · Cited by 159
“…kinase (DAPK) (Jang et al , 2002; Ramesh et al , 2008; Heldin et al , 2009), as well as the arrest of proliferation by the induction of cyclin-dependent kinase inhibitors such as p21 CIP1 , are examples of tumor-suppressive mechanisms (Hannon & Beach, 1994; Datto et al , 1995; Massague, 2008).”
Skp2 in the ubiquitin‐proteasome system: A comprehensive review
Asmamaw, M. D., Liu, Y., Zheng, Y., Shi, X., & Liu, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21675 · Cited by 175
Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
Pei, X.-H., & Xiong, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208611 · Cited by 158
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Sotiropoulou, G., Pampalakis, G., Lianidou, E., & Mourelatos, Z. (2009) · RNA · doi:10.1261/rna.1534709 · Cited by 157
“TGF-b is a major regulator of cell signaling that transduces antigrowth signals via multiple pathways, but mainly through prevention of phosphorylation and inactivation of the tumor suppressor protein Rb, an effect mediated by p15 (Hannon and Beach 1994).”
BackgroundSekiya, T., Adachi, S., Kohu, K., Yamada, T., Higuchi, O., Furukawa, Y., Nakamura, Y., Nakamura, T., Tashiro, K., Kuhara, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310876200 · Cited by 156
Feng, X.-H., Filvaroff, E. H., & Derynck, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24237 · Cited by 155
Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 153
Transforming growth factor-β in breast cancer: A working hypothesis
Reiss, M., & Barcellos-Hoff, M. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005865812918 · Cited by 127
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
Bai, X., Yi, M., Jiao, Y., Chu, Q., & Wu, K. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s224013 · Cited by 153
Ball, K. L., Laín, S., Fåhræus, R., Smythe, C., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00029-7 · Cited by 171
Platz, A., Hansson, J., Mansson-Brahme, E., Lagerlof, B., Linder, S., Ringborg, U., Lundqvist, E., Sevigny, P., & Inganas, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.697 · Cited by 154
Cell cycle in mouse development
Ciemerych, M. A., & Siciński, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208608 · Cited by 172
Larsson, J., Blank, U., Helgadottir, H., Björnsson, J. M., Ehinger, M., Goumans, M.-J., Fan, X., Levéen, P., & Karlsson, S. (2003) · Blood · doi:10.1182/blood-2003-04-1300 · Cited by 152
Kang, H.-Y., Lin, H.-K., Hu, Y.-C., Yeh, S., Huang, K.-E., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061305498 · Cited by 152
Transforming growth factor‐β in cutaneous melanoma
Javelaud, D., Alexaki, V. I., & Mauviel, A. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00450.x · Cited by 180
“Also, the two pathways have been shown to exert opposite effects on cyclin-dependent kinases during the G1 phase of the cell cycle (Hannon and Beach, 1994; Reynisdottir et al., 1995), which may also contribute to Ras-dependent attenuation of TGF-b-induced tumor suppression.”
Backgroundp57KIP2: “Kip”ing the Cell under Control
Pateras, I. S., Apostolopoulou, K., Niforou, K., Kotsinas, A., & Gorgoulis, V. G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0317 · Cited by 149
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Lazarova, M., & Steinle, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02689 · Cited by 149
Physiology and pathophysiology of the growth plate
Ballock, R. T., & O’Keefe, R. J. (2003) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.10014 · Cited by 190
Gene amplification in human gliomas
Collins, V. P. (1995) · Glia · doi:10.1002/glia.440150309 · Cited by 149
Walker, G. J., Flores, J. F., Glendening, J. M., Lin, A. H., Markl, I. D. C., & Fountain, J. W. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199806)22:2<157::aid-gcc11>3.0.co;2-n · Cited by 161
Cell division and the nervous system: regulating the cycle from neural differentiation to death
Ross, M. E. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)89622-6 · Cited by 146
Talmud, P. J., Cooper, J. A., Palmen, J., Lovering, R., Drenos, F., Hingorani, A. D., & Humphries, S. E. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095489 · Cited by 147
Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control
Oelgeschläger, T. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10058 · Cited by 169
“INK4 proteins (inhibitors of CDK4 and CDK6) can directly block cyclin D-dependent kinase activity, causing cells to arrest in G1 phase (Serrano et al., 1993; Guan et al., 1994; Hannon and Beach, 1994; Kamb et al., 1994; Nobori et al., 1994; Chan et al., 1995; Hirai et al., 1995; Sherr, 1996).”
BackgroundZhang, S., Ramsay, E. S., & Mock, B. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2429 · Cited by 147
Expression of Chr9p21 genes CDKN2B (p15), CDKN2A (p16, p14) and MTAP in human atherosclerotic plaque
Holdt, L. M., Sass, K., Gäbel, G., Bergert, H., Thiery, J., & Teupser, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.029 · Cited by 143
Calonge, M. J., & Massagué, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33637 · Cited by 146
Epithelial–Mesenchymal Transition in Development and Cancer
Micalizzi, D. S., & Ford, H. L. (2009) · Future Oncology · doi:10.2217/fon.09.94 · Cited by 156
Cyclin-Dependent Kinase Regulation during G1 Phase and Cell Cycle Regulation by TGF-ß
Ravitz, M. J., & Wenner, C. E. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60099-8 · Cited by 168
The INK4 Family of CDK Inhibitors
Carnero, A., & Hannon, G. J. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_3 · Cited by 189
Nicolás, F. J., & Hill, C. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206420 · Cited by 160
Sangfelt, O., Erickson, S., Castro, J., Heiden, T., Gustafsson, A., Einhorn, S., & Grandér, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202609 · Cited by 160
Han, E. K.-H., Begemann, M., Sgambato, A., Soh, J. W., Doki, Y., Xing, W. Q., Liu, W., & Weinstein, I. B. (1996) · PubMed · Cited by 158
Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
Arendt, T., Holzer, M., & Gärtner, U. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050104 · Cited by 137
Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer
DiCiommo, D. P., Gallie, B. L., & Bremner, R. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0326 · Cited by 163
New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy
Bury, M., Calvé, B. L., Ferbeyre, G., Blank, V., & Lessard, F. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.01.010 · Cited by 144
Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3
Kawamura, C., Kizaki, M., Yamato, K., Uchida, H., Fukuchi, Y., Hattori, Y., Koseki, T., Nishihara, T., & Ikeda, Y. (2000) · Blood · doi:10.1182/blood.v96.6.2005 · Cited by 150
Wimardhani, Y. S., Suniarti, D. F., Freisleben, H. J., Wanandi, S. I., Siregar, N. C., & Ikeda, M. (2014) · Journal of Oral Science · doi:10.2334/josnusd.56.119 · Cited by 147
Physical Interaction of Mammalian CDC37 with CDK4
Dai, K., Kobayashi, R., & Beach, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22030 · Cited by 134
Serra, S., & Chetty, R. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205216 · Cited by 131
Deletions of the INK4A Gene in Superficial Bladder Tumors
Orlow, I., LaRue, H., Osman, I., Lacombe, L., Moore, L., Rabbani, F., Meyer, F., Fradet, Y., & Cordon‐Cardo, C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65105-x · Cited by 147
Molecular Mechanisms of Transforming Growth Factor- Signaling
Hu, P. P.-C., Datto, M., & Wang, X. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0333 · Cited by 161
Yang, Z., Oemar, B. S., Carrel, T., Kipfer, B., Julmy, F., & Lüscher, T. F. (1998) · Circulation · doi:10.1161/01.cir.97.2.181 · Cited by 145
Iavarone, A., & Massagué, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.916 · Cited by 132
Cross-talk between protein kinase C and multifunctional Ca2+/calmodulin-dependent protein kinase.
MacNicol, M., & Schulman, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49824-4 · Cited by 131
Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
Guo, S.-X., Taki, T., Ohnishi, H., Piao, H., Tabuchi, K., Bessho, F., Hanada, R., Yanagisawa, M., & Hayashi, Y. (2000) · Leukemia Research · doi:10.1016/s0145-2126(99)00158-7 · Cited by 137
TGF-β signaling in cell fate control and cancer
Yu, Y., & Feng, X. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.007 · Cited by 138
Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth
Landen, J. W., Hau, V. S., Wang, M., Davis, T. P., Ciliax, B. J., Wainer, B. H., Meir, E. G. V., Glass, J. D., Joshi, H. C., & Archer, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0360 · Cited by 130
INK4d-Deficient Mice Are Fertile Despite Testicular Atrophy
Zindy, F., van Deursen, J., Grosveld, G., Sherr, C. J., & Roussel, M. F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.372-378.2000 · Cited by 130
Demers, G. W., Espling, E., Harry, J. B., Etscheid, B. G., & Galloway, D. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6862-6869.1996 · Cited by 129
Franklin, D. S., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.10.1587 · Cited by 128
Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic Factors
Servant, M. J., Coulombe, P., Turgeon, B., & Meloche, S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.3.543 · Cited by 146
“…specifically interacts with Cdk4 and Cdk6 to prevent cyclin D-Cdk assembly or enters into stable ternary complexes with cyclin D-Cdk, resulting in complexes that are catalytically inactive (Serrano et al., 1993; Guan et al., 1994; Hannon and Beach, 1994; Chan et al., 1995; Hirai et al., 1995).”
BackgroundAlterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T- cell leukemia/lymphoma
Roberta Morosetti, A., Kawamata, N., Gombart, A., Cw, M., Hatta, Y., Hirama, T., Jw, S., Tomonaga, M., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.5.1924.bloodjournal8651924 · Cited by 134
Chen, H., Bai, M.-H., Zhang, T., Li, G., & Liu, M. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2870 · Cited by 147
Cocolakis, E., Lemay, S., Ali, S., & Lebrun, J.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010768200 · Cited by 127
Yamada, N., Kato, M., Yamashita, H., Nistér, M., Miyazono, K., Heldin, C., & Funa, K. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620405 · Cited by 127
Griswold-Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C., & Derynck, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6595 · Cited by 127
Doria, A. (2008) · JAMA · doi:10.1001/jama.2008.649 · Cited by 127
Al-Douahji, M., Brugarolas, J., Brown, P. A., Stehman‐Breen, C. O., Alpers, C. E., & Shankland, S. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00728.x · Cited by 135
TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
Bright, J. J., & Sriram, S. (1998) · PubMed · Cited by 126
Alpha Interferon Suppresses the Cyclin D3 and cdc25A Genes, Leading to a Reversible G 0 -Like Arrest
Tiefenbrun, N., Melamed, D., Levy, N., Resnitzky, D., Hoffmann, I., Reed, S. I., & Kimchi, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3934 · Cited by 126
Cudejko, C., Wouters, K., Fuentes, L., Hannou, S. A., Paquet, C., Bantubungi, K., Bouchaert, E., Vanhoutte, J., Fleury, S., Remy, P., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313106 · Cited by 125
Romero–Gallo, J., Sözmen, E. G., Chytil, A., Russell, W. E., Whitehead, R. H., Parks, W. T., Holdren, M. S., Her, M. F., Gautam, S., Magnuson, M. A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208475 · Cited by 135
Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I
Höllsberg, P. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.308-333.1999 · Cited by 144
Mammalian anti proliferative signals and their targets
Massagué, J., & Polyák, K. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90059-4 · Cited by 130
Meirelles, K., Benedict, L. A., Dombkowski, D., Pépin, D., Preffer, F. I., Teixeira, J. M., Tanwar, P. S., Young, R. H., MacLaughlin, D. T., Donahoe, P. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120733109 · Cited by 136
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression
Nozaki, M., Tada, M., Kobayashi, H., Zhang, C. L., Sawamura, Y., Abe, H., Ishii, N., & Meir, E. G. V. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.2.124 · Cited by 122
Altered Transforming Growth Factor β Signaling in Epithelial Cells when Ras Activation Is Blocked
Hartsough, M. T., Frey, R. S., Zipfel, P. A., Buard, A., Cook, S. J., McCormick, F., & Mulder, K. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22368 · Cited by 122
Villuendas, R., Sánchez‐Beato, M., Martínez, J. C., Sáez, A. I., Martínez–Delgado, B., García, J. F., Mateo, M. S., Sánchez‐Verde, L., Benitez, J. J., Martínez, P., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65630-1 · Cited by 132
Stability and folding of the tumour suppressor protein p16 1 1Edited by J. Karn
Tang, K. S., Guralnick, B. J., Wang, W. K., Fersht, A. R., & Itzhaki, L. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2420 · Cited by 134
“The original cDNA clone of p16 was N-terminally truncated by eight amino acid residues (Serrano et al., 1993), and later the full-length sequence of 156 residues was discovered (Hannon & Beach, 1994).”
BackgroundRich, J. N., Zhang, M., Datto, M. B., Bigner, D. D., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35053 · Cited by 120
Concurrent Hypermethylation of Multiple Genes Is Associated with Grade of Oligodendroglial Tumors
Dong, S.-M., Pang, J. C., Poon, W. S., Hu, J., To, K., Chang, A. R., & Ng, H. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.808 · Cited by 120
Li, Y., Nagai, H., Ohno, T., Yuge, M., Hatano, S., Ito, E., Mori, N., Saito, H., & Kinoshita, T. (2002) · Blood · doi:10.1182/blood-2001-11-0026 · Cited by 120
For the Public's Health: the Role of Measurement in Action and Accountability
Mays, G. P. (2010) · Cited by 120
A common variant near TGFBR3 is associated with primary open angle glaucoma
Li, Z., Allingham, R. R., Nakano, M., Jia, L., Chen, Y., Ikeda, Y., Mani, B., Chen, L.-J., Kee, C., Garway‐Heath, D. F., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv128 · Cited by 123
Inhibition of TGF-β Signaling Promotes Human Pancreatic β-Cell Replication
Dhawan, S., Dirice, E., Kulkarni, R. N., & Bhushan, A. (2016) · Diabetes · doi:10.2337/db15-1331 · Cited by 119
Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A
Arima, N., Kao, C., Licht, T., Padmanabhan, R., Sasaguri, Y., & Padmanabhan, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008329200 · Cited by 131
The Gene for Multiple Familial Trichoepithelioma Maps to Chromosome 9p21
Harada, H., Hashimoto, K., & Ko, M. S. H. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12297860 · Cited by 125
TGF-β Inhibits IL-12-Induced Activation of Jak-STAT Pathway in T Lymphocytes
Bright, J. J., & Sriram, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1772 · Cited by 119
Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.
Nakanishi, M., Adami, G. R., Robetorye, R. S., Noda, A., Venable, S. F., Dimitrov, D., Pereira-Smith, O. M., & Smith, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4352 · Cited by 119
Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1
Gebhardt, A., Frye, M., Herold, S., Benitah, S. A., Braun, K., Samans, B., Watt, F. M., Elsässer, H.-P., & Eilers, M. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200506057 · Cited by 118
“Of these inhibitors, p15Ink4b is induced by TGF- and mediates the TGF- –induced arrest of proliferation (Hannon and Beach, 1994).”
BackgroundCell cycle proteins and the development of oral squamous cell carcinoma
Schoelch, M. L., Regezi, J. A., Dekker, N. P., Ng, I. O., McMillan, A., Ziober, B. L., Le, Q., Silverman, S., & Fu, K. K. (1999) · Oral Oncology · doi:10.1016/s1368-8375(98)00098-0 · Cited by 132
Suzuki, T., Narita, T., Uchida-Toita, M., & Yoshida, M. (1999) · Virology · doi:10.1006/viro.1999.9760 · Cited by 131
Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan, K. L., Jenkins, C. W., Li, Y., O'Keefe, C. L., Noh, S., Wu, X., Zariwala, M., Matera, A. G., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.1.57 · Cited by 118
TGFβ pathway inhibition in the treatment of non-small cell lung cancer
Eser, P. Ö., & Janne, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.004 · Cited by 122
Bostwick, D. G., Alexander, E. E., Singh, R., Shan, A., Qian, J., Santella, R. M., Oberley, L. W., Yan, T., Zhong, W., Jiang, X., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<187::aid-cncr25>3.0.co;2-x · Cited by 273
Sánchez‐Beato, M., Sáez, A. I., Martínez-Montero, J. C., Mateo, M. S., Sánchez‐Verde, L., Villuendas, R., Troncone, G., & Piris, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 129
p57Kip2 Regulates Actin Dynamics by Binding and Translocating LIM-kinase 1 to the Nucleus
Yokoo, T., Toyoshima, H., Miura, M., Wang, Y., Iida, K. T., Suzuki, H., Sone, H., Shimano, H., Gotoda, T., Nishimori, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309334200 · Cited by 115
Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., et al. (1996) · Blood · doi:10.1182/blood.v87.12.4949.bloodjournal87124949 · Cited by 115
An Updated Review on the Genetics of Primary Open Angle Glaucoma
Abu‐Amero, K. K., Kondkar, A. A., & Chalam, K. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226135 · Cited by 129
Kourea, H. P., Cordon‐Cardo, C., Dudas, M. E., Leung, D. H. Y., & Woodruff, J. M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65508-3 · Cited by 117
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.